Average Co-Inventor Count = 5.88
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (18 from 4,945 patents)
2. Other (1 from 832,843 patents)
3. Roche Innovation Center Copenhagen A/s (1 from 46 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
20 patents:
1. 12303525 - Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
2. 12259380 - Oligonucleotides for inducing paternal UBE3A expression
3. 12116576 - Oligonucleotides for modulating SCN9A expression
4. 11898145 - Enhanced oligonucleotides for inhibiting RTEL1 expression
5. 11852627 - Oligonucleotides for inducing paternal UBE3A expression
6. 11732262 - Use of FUBP1 inhibitors for treating hepatitis B virus infection
7. 11542501 - Antisense oligonucleotides targeting ATXN3
8. 11534452 - Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection
9. 11484546 - Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
10. 11466081 - Oligonucleotides for reduction of PD-L1 expression
11. 11320421 - Oligonucleotides for inducing paternal UBE3A expression
12. 11286485 - Oligonucleotides for modulating ATXN2 expression
13. 11066669 - Oligonucleotides for modulating ATXN2 expression
14. 10953034 - Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
15. 10829555 - Oligonucleotides for reduction of PD-L1 expression